Annual report pursuant to Section 13 and 15(d)

Consolidated Statements of Loss and Comprehensive Loss

v3.20.1
Consolidated Statements of Loss and Comprehensive Loss - USD ($)
$ in Thousands
12 Months Ended
Dec. 31, 2019
Dec. 31, 2018
Dec. 31, 2017
EXPENSES      
Research and development $ 9,674 $ 5,868 $ 3,101
General and administrative 6,854 6,945 3,531
Total operating expenses 16,528 12,813 6,632
OTHER INCOME (EXPENSE)      
Interest income 170 171 21
Bargain purchase gain [note 2]     1,272
Contingent value rights recovery [note 2]     200
Gain on warrants     150
Loss on disposition of intangible asset [note 5]     (8,610)
Other expenses (37) (45) (35)
Total other income 133 126 (7,002)
Net loss before income taxes (16,395) (12,687) (13,634)
Recovery of deferred income taxes [note 5]     3,051
Net Loss (16,395) (12,687) (10,583)
Comprehensive loss $ (16,395) $ (12,687) $ (10,583)
Basic and diluted net loss per common share [note 11 [g]] $ (1.99) $ (3.61) $ (22.07)
Shares used in computation of basic and diluted net loss per common share [note 11 [g]] 8,246,400 3,510,217 479,442